Results 11 to 20 of about 12,281 (206)
Primary myelofibrosis: current therapeutic options
Revista Brasileira de Hematologia e Hemoterapia, 2016 Primary myelofibrosis is a Philadelphia-negative myeloproliferative neoplasm characterized by clonal myeloid expansion, followed by progressive fibrous connective tissue deposition in the bone marrow, resulting in bone marrow failure.
Paula de Melo Campos
doaj +5 more sources
Haematologica, 2013 Megakaryocytes release platelets into the bloodstream by elongating proplatelets. In this study, we showed that human megakaryocytes constitutively release Transforming Growth Factor β1 and express its receptors.
Stefania Badalucco +9 more
doaj +3 more sources
Treatment of myelofibrosis and primary erythermalgia [PDF]
American Journal of Hematology, 1993 Şînasi Özsoylu
openalex +3 more sources
Extramedullary myeloid tumors in primary myelofibrosis [PDF]
Cancer, 1965 Philip Lieberman +2 more
openalex +4 more sources
Coexistence of primary myelofibrosis and chronic lymphocytic leukemia
Blood and Lymphatic Cancer: Targets and Therapy, 2014 Sonja Burgstaller, Josef Thaler Klinikum Wels-Grieskirchen, Abteilung für Innere Medizin IV, Wels, AustriaAbstract: Coexistence of two hematologic malignancies in one patient is generally a rare phenomenon.
Burgstaller S, Thaler J
doaj +2 more sources
Pathophysiology of and Therapy for Primary Myelofibrosis
Nihon Naika Gakkai Zasshi, 2007 Kazuya Shimoda
openalex +4 more sources
Hepatology, EarlyView., 2022 Mesenchymal stem cells subset, educated by TNF‐α, are involved to generate inflammatory microenvironment and promote hepatocarcinogenesis Abstract Background and Aims Increasing evidence suggests that mesenchymal stem cells (MSCs) home to injured local tissues and the tumor microenvironment in the liver.
Chen Zong +9 more
wiley +1 more source
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
Hepatology, EarlyView., 2022 Diagram of the activation of the profibrotic and procontractile Janus kinase 2 (JAK2)/Ras homolog family member A/Rho‐kinase pathway and the inhibition of phosphorylated JAK2 by pacritinib to inhibit hepatic stellate cell activity. Abstract Background and Aims Janus kinase 2 (JAK2) signaling is increased in human and experimental liver fibrosis with ...
Sandra Torres +21 more
wiley +1 more source
Disseminated tuberculosis with myelofibrosis presentation: a case report
Journal of Medical Case Reports, 2021 Background Primary myelofibrosis is a rare myeloproliferative disorder in middle-aged and old adults and should be distinguished from secondary and reactive causes of bone marrow fibrosis because, in reactive fibrosis, treatment approaches depend on the ...
Mahdi Khatuni +3 more
doaj +1 more source
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity
Frontiers in Pediatrics, 2022 Myelofibrosis is a rare myeloproliferative disorder. The detailed descriptions of myelofibrosis in children and adolescents is limited to a few case series and case reports describing fewer than 100 patients, thus suggesting the extreme rarity of this ...
Fabiola Guerra +12 more
doaj +1 more source